Skip to main content
Nadav Ahituv on Muck Rack

Nadav Ahituv

San Francisco, Walnut Creek
As seen in: MSN, Nature, Yahoo News, Yahoo News Malaysia, The Conversation, Genome Biology, Live Science, Yahoo, BioRxiv, Cell Press and
Professor, Department of Bioengineering and Therapeutic Sciences, Director, Institute for Human Genetics, UCSF
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nadav

Contact Nadav, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Simultaneous epigenomic profiling and regulatory activity measurement using e2MPRA - Nature Communications

|
By Zicong Zhang, Ilias Georgakopoulos-Soares, Guillaume Bourque, Nadav Ahituv
| Nature Verified
Abstract Using various biochemical assays that identify transcription factor (TF) binding and histone modifications, cis-regulatory elements (CREs) can be annotated in a genome-wide manner. However, these assays are descriptive and require functional validation. To the best of our knowledge, no technology can simultaneously analyze the regulatory function and epigenomic modifications of a specific sequence.
Open in Who Shared Issue with article?

Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders - Nature

|
By Elizabeth Hamada, Beniamin Krupkin, Atehsa Sahagun, Sunrae E. Taloma, Ying Li, Lia Min, Paul Jenkins, Jeanne T. Paz, Stephan Sanders, Nadav Ahituv
| Nature Verified
Correction to: Nature https://doi.org/10.1038/s41586-025-09522-w Published online 17 September 2025 In the version of the article initially published, in Fig. 1b, the exons in the top line depicting the Scn2a allele were flipped and read “3 4 5” and have now been corrected to “5 4 3” in the HTML and PDF versions of the article. About this article Tamura, S., Nelson, A.D., Spratt, P.W.E. et al. Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders. Nature (2025).
Open in Who Shared Issue with article?

CRISPR activation for SCN2A-related neurodevelopmental disorders - Nature

|
By Elizabeth Hamada, Atehsa Sahagun, Sunrae E. Taloma, Ying Li, Lia Min, Paul Jenkins, Jeanne T. Paz, Stephan Sanders, Nadav Ahituv, Beniamin Krupkin
| Nature Verified
Abstract Most neurodevelopmental disorders with single gene diagnoses act via haploinsufficiency, in which only one of the two gene copies is functional1. SCN2A haploinsufficiency is one of the most frequent causes of neurodevelopmental disorder, often presenting with autism spectrum disorder, intellectual disability and, in a subset of children, refractory epilepsy2.
Open in Who Shared Issue with article?
See all 41 licensed articles (43 Total)